Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Active, not recruiting · NCT06282874 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases | Brain Metastases, Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, neoplastic meningitis, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, tumor of meninges | Active, not recruiting | Phase 4 | 2026-04-09 | NCT06282874 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangdong Association of Clinical Trials | 20 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guangdong Provincial Perople's Hospital | Guangzhou | China | 1 |
| Tenth Affiliated Hospital, Southern Medical University (Dongguan people's hospital) | Dongguan | China | 1 |
| The First People's Hospital of Foshan | Foshan | China | 1 |